The enteral nutrition market has witnessed significant growth over the past few years owing to the increasing prevalence of chronic diseases such as cancer and neurological disorders. Enteral nutrition products provide balanced nutrition to patients who cannot swallow or digest food or absorb sufficient nutrients or liquids from food due to certain medical conditions or treatments. There has been a rise in conditions such as malnutrition, short bowel syndrome, cancer, gastrointestinal diseases and neurological disorders which require enteral nutrition support for treatment. The need for tube feeding to deliver liquids, nutrition, and medications to the gastrointestinal tract is also increasing. The Global Enteral Nutrition Market is estimated to be valued at US$ 3.1 Bn in 2024 and is expected to exhibit a CAGR of 5.8% over the forecast period 2023 to 2030.
Key Takeaways
Key players operating in the Enteral Nutrition market are Abbott, Nestlé S.A., Danone S.A., Fresenius Kabi AG, Mead Johnson & Company, LLC, Braun Melsungen AG, Otsuka Pharmaceutical Co., Ltd, Meiji Holdings Co., Ltd., Bahrain Pharma, Bionova Lifesciences, Global Health Products Inc., Victus Inc., Curtis Health Caps SP.
The growing pool of cancer and neurological disorder patients requiring tube feeding is creating significant opportunities for enteral nutrition products. Nutrition support and meeting dietary requirements is crucial for positive treatment outcomes in chronic diseases. Enteral nutrition product providers are focusing on expanding their global footprint to tap the demand from developing nations through strategic partnerships and acquisitions.
Major players in the enteral nutrition market are focused on expanding their global presence. Strategic acquisitions and partnerships allow companies to strengthen their distribution networks and access new markets particularly in developing countries. For instance, Abbott acquired Ross Products division of AbbVie in 2014 to enhance its pediatric and adult medical nutrition business.
Market Drivers
Growth in the target patient population for enteral nutrition driven by rising incidence of chronic disease states like cancer and neurological disorders is a major market driver. Between 2020-2030, cancer cases and mortality is estimated to increase by around 70% globally. Neurological disorders are also expected to rise significantly owing to aging population and improved diagnosis. Increasing life expectancy and better management of chronic conditions has enlarged the pool of patients requiring long-term enteral nutrition support.
The growing preference for home-based enteral feeding due to improved product formulations and administration devices has further stimulated demand. Home enteral nutrition offers advantages like cost-savings, convenience and better quality of life. However, limited clinical evidence, lack of reimbursement policies and stringent regulations continue to restrain market growth to some extent.
Segment Analysis
The enteral nutrition market is dominating by the sub segment of enteral feeding tubes. Enteral feeding tubes lead to better nutrient availability and absorption in the gastrointestinal tract. Conditions such as preterm birth complications, gastrointestinal disorders, and neurological disorders require continuous nutrition support which increases the demand of enteral feeding tubes. Enteral feeding tubes prevent reflux and ensure proper positioning of the feeding tube tip within the stomach. The placement of feeding tubes is convenient and allows early initiation of feeding which aids recovery process.
Global Analysis
North America region accounts for the major share in the enteral nutrition market and is anticipated to witness the fastest growth during the forecast period. This is mainly due to the increased prevalence of chronic diseases, rising geriatric population, developed healthcare infrastructure and availability of skillful professionals. The U.S. dominates the North America enteral nutrition market owing to growing cases of preterm birth, cancer, neurological disorders and malnourishment among individuals in nursing homes and long-term care facilities. Asia Pacific region is expected to grow steadily due to increasing awareness regarding clinical nutrition, improving healthcare infrastructure and rising per capita income. Factors such as presence of vast patient pool, upgradation of healthcare facilities and rise in insurance coverage support the market growth in Asia Pacific region.
No comments:
Post a Comment